SCHEMBL7700639

SCHEMBL7700639

CCOC(=O)C1=Cc2cccc(C=O)c2OCC1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.40
LMNA P02545 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
CA12 O43570 2/20 0.36
CA9 Q16790 2/20 0.36
CA1 P00915 1/20 0.36
CA2 P00918 1/20 0.36
CA7 P43166 1/20 0.36
CA14 Q9ULX7 1/20 0.36
GAA P10253 2/20 0.36
MGAM O43451 1/20 0.36
AMY1A P0DUB6 1/20 0.36
SI P14410 1/20 0.36
MGAM2 Q2M2H8 1/20 0.36
TP53 P04637 2/20 0.36
POLB P06746 1/20 0.36
HPGD P15428 1/20 0.36
CYP1A2 P05177 1/20 0.35
TSHR P16473 1/20 0.35
PREP P48147 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7697123 0.90 PREP (0.38) ALDH1A1LMNASMN1; SMN2GAAMGAM
SCHEMBL7878684 0.87 USP2 (0.41) ALDH1A1LMNASMN1; SMN2CA12CA9
SCHEMBL7702052 0.86 L3MBTL1 (0.38) ALDH1A1LMNACA12CA9CA1
SCHEMBL7703504 0.86 KDM4E (0.47) ALDH1A1SMN1; SMN2CA12CA9CA1
SCHEMBL7702054 0.86 L3MBTL1 (0.38) ALDH1A1LMNACA12CA9CA1
SCHEMBL7703505 0.86 KDM4E (0.47) ALDH1A1SMN1; SMN2CA12CA9CA1
SCHEMBL7700005 0.86 CA12 (0.46) ALDH1A1SMN1; SMN2CA12CA9CA1
SCHEMBL7385304 0.86 MAPT (0.39) ALDH1A1CA12CA9CA1CA2
SCHEMBL7699846 0.85 TSHR (0.46) ALDH1A1LMNASMN1; SMN2CA12CA9
SCHEMBL7696668 0.85 CA12 (0.48) ALDH1A1LMNACA12CA9CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6346527-B1 1-BENZOXEPIN DERIVATIVES USED IN THE PREVENTION OF SODIUM AND HYDROGEN ION EXCHANGE; CARDIOVASCULAR, KIDNEY AND BRAIN DISORDER TREATMENT; ARTERIOSCLEROSIS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2002-02-12 US disclosed
EP-1073650-A1 GUANIDINE DERIVATIVES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2001-02-07 EP disclosed
WO-1999055690-A1 GUANIDINE DERIVATIVES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1999-11-04 WO disclosed